Intra-Cellular Therapies Inc (ITCI.OQ)
ITCI.OQ on NASDAQ Stock Exchange Global Select Market
19.71USD
12:09pm EDT
19.71USD
12:09pm EDT
Change (% chg)
$0.55 (+2.87%)
$0.55 (+2.87%)
Prev Close
$19.16
$19.16
Open
$19.28
$19.28
Day's High
$19.86
$19.86
Day's Low
$19.27
$19.27
Volume
16,181
16,181
Avg. Vol
121,547
121,547
52-wk High
$25.74
$25.74
52-wk Low
$10.83
$10.83
Select another date:
Thu, May 3 2018
BRIEF-Intra-Cellular Therapies Reports Q1 Loss Per Share $0.65
* INTRA-CELLULAR THERAPIES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
BRIEF-Intra-Cellular Therapies Announces Positive Pre-NDA Meeting With FDA For Schizophrenia Treatment
* INTRA-CELLULAR THERAPIES ANNOUNCES POSITIVE PRE-NDA MEETING WITH FDA FOR LUMATEPERONE FOR THE TREATMENT OF SCHIZOPHRENIA
BRIEF-Intra-Cellular Therapies Reports Q4 Loss Per Share $0.56
* INTRA-CELLULAR THERAPIES REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Select another date:
- Intrinsic Value Of Acadia: Deep Dive And Financial Analysis
- Intra-Cellular Therapies' (ITCI) CEO Sharon Mates on Q2 2018 Results - Earnings Call Transcript
- Aptinyx IPO: It Collaborated With Allergan, But Shares Are Not Cheap
- 3 Things In Biotech, May 7: Novartis Thyroid Breakout, Redhill's Stomach Bugs, Intra-Cellular Update On Schizoid Drugs
- Biotech Forum Daily Digest For The Ides Of March
- Intra-Cellular Therapies' (ITCI) CEO Sharon Mates on Q4 2017 Results - Earnings Call Transcript